Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Subject collections
    • Interviews
    • Sign up for alerts
  • About us
    • About DMM
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Outstanding paper prize
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact DMM
    • Advertising
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Disease Models & Mechanisms
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Disease Models & Mechanisms

Advanced search

RSS   Twitter   Facebook   YouTube

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Subject collections
    • Interviews
    • Sign up for alerts
  • About us
    • About DMM
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Outstanding paper prize
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact DMM
    • Advertising
    • Feedback
FIRST PERSON
First person – Tamio Furuse and Hiroshi Mizuma
Disease Models & Mechanisms 2019 12: dmm042127 doi: 10.1242/dmm.042127 Published 12 September 2019
  • Article
  • Figures & tables
  • Info & metrics
  • PDF
Loading

ABSTRACT

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Tamio Furuse and Hiroshi Mizuma are co-first authors on ‘ A new mouse model of GLUT1 deficiency syndrome exhibits abnormal sleep-wake patterns and alterations of glucose kinetics in the brain’, published in DMM. Tamio is a research and development scientist in the lab of Masaru Tamura at RIKEN BioResource Research Center, Japan, investigating the development of a new phenotyping platform of mutant mice. Hiroshi is a research scientist in the lab of Yasuyoshi Watanabe at RIKEN Center for Biosystems Dynamics Research, Japan, investigating functional brain PET imaging in mice modelling human disease.

Embedded Image

Tamio Furuse and Hiroshi Mizuma

How would you explain the main findings of your paper to non-scientific family and friends?

TF: GLUT1 deficiency syndrome (GLUT1DS), an intractable form of epilepsy, is caused by dysfunction of glucose transporter 1, which delivers glucose to the brain. Traditional anticonvulsants are not effective for GLUT1DS. In order to develop new drugs and therapeutics, animal models of GLUT1DS are necessary. As such, our findings may help patients with intractable epilepsy, GLUT1DS, by providing a good model for the disease.

HM: In this study, we performed 18F-FDG PET, with the aim of understanding brain glucose kinetics in a GLUT1DS mouse model. PET imaging has the main advantage of enabling quantitative, non-invasive, in vivo measurement of molecular functionality. To our knowledge, this is the first study to measure, quantitatively, brain glucose kinetics in the GLUT1DS mouse model under non-anesthetized conditions. In the future, we hope that our findings will contribute to new aspects of clinical investigation in patients with GLUT1DS.

“To our knowledge, this is the first study to measure, quantitatively, brain glucose kinetics in the GLUT1DS mouse model under non-anesthetized conditions” – Hiroshi Mizuma

What are the potential implications of these results for your field of research?

TF: ENU mutagenesis, a traditional methodology, is still able to provide a useful insight into disease models and could be harmonized with phenotyping methods based on advanced technology such as PET imaging.

HM: We have developed a methodology for brain PET imaging in mice under non-anesthetized conditions. By using this, we can gain insight into intrinsic functioning of the brain during near-physiological conditions. We have measured brain glucose metabolic activity not only in this GLUT1DS mouse model but also in other mouse models of human disease, such as dementia and autistic spectrum disorder. Our imaging method also enabled the detection of regional abnormal glucose metabolism in these mouse models.

What are the main advantages and drawbacks of the model system you have used as it relates to the disease you are investigating?

TF: The main advantage is that brain structures are conserved between human and mice. A drawback is that advanced social behavior in humans, such as the use of language, are not reproduced in mice.

What has surprised you the most while conducting your research?

TF: The founder mouse of the Glut1 mutant line exhibited visible seizures. At the beginning of genetic analysis of the mutant, I predicted that the mutated gene was expressed in neurons or glia which directly control brain function. However, the Glut1 gene is expressed in the blood-brain barrier, not in neurons.

HM: Although we were concerned about whether our PET imaging method could be used to obtain data of glucose kinetics in a mouse as in human PET studies, our results indicate the hypofunction of glucose transport in the brain in GLUT1DS model mice. We were surprised that this mouse model showed an increase in the uptake of FDG in the brain, resulting in a compensatory upregulation of intracellular high glucose phosphorylation against low glucose transporter function.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Visible seizures observed in the M100200 mutant. Upper left, normal gait; upper right, ataxic gait; lower left, convulsive seizure; lower right, lowered posture.

Describe what you think is the most significant challenge impacting your research at this time and how will this be addressed over the next 10 years?

TF: Virtual reality (VR) technology has been implemented in mouse behavioral phenotype analysis. VR technology not only enables various expansive experiments in a limited area but also enables brain-functional imaging or optogenetic experiments simultaneously with behavioral analyses. In addition, it may contribute to the studies which investigate the effects of VR experiences on human brain function, experiments which are difficult to conduct in humans.

“I think that one important thing is to develop and collaborate with different biological fields.” – Hiroshi Mizuma

HM: I think that one important thing is to develop and collaborate with different biological fields. For instance, it is becoming necessary that, to further advancement of bioimaging scanners, a deep understanding of brain function using small mammalian animals is needed. To overcome this, I am very interested in cutting-edge technologies to detect radiation in the universe, a field of astrophysics. By using these technologies, it will be possible to have high spatial resolution and to measure multiple nuclides simultaneously, giving insight into the complexity and interaction of brain functions.

What changes do you think could improve the professional lives of early-career scientists?

TF: Experienced scientists have knowledge on how to survive as scientists. I recommend early-career scientists collaborate with scientists who have long, successful careers.

“Experienced scientists have knowledge on how to survive as scientists.” – Tamio Furuse

HM: It is important to take on research which concerns not only your field but also other scientific fields. You never know how your skills are useful in other fields. I think interacting with as many researchers as possible is one way to expand your own potential.

What's next for you?

TF: To develop a novel methodology to integrate multiple methodologies which can monitor mouse brain function.

HM: I would like to challenge the innovative technologies involved in in vivo brain imaging based on a new interdisciplinary concept.

Footnotes

  • Tamio Furuse's contact details: Japan Mouse Clinic, RIKEN BioResource Research Center, Tsukuba, Ibaraki 305-0074, Japan;

    Hiroshi Mizuma's contact details: Laboratory for Pathophysiological and Health Science, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo 650-0047, Japan.

    E-mails: tamio.furuse{at}riken.jp; mizuma_hiroshi{at}riken.jp

  • © 2019. Published by The Company of Biologists Ltd
http://creativecommons.org/licenses/by/4.0

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Reference

  1. ↵
    1. Furuse, T.,
    2. Mizuma, H.,
    3. Hirose, Y.,
    4. Kushida, T.,
    5. Yamada, I.,
    6. Miura, I.,
    7. Masuya, H.,
    8. Funato, H.,
    9. Yanagisawa, M.,
    10. Onoe, H. et al.
    (2019). A new mouse model of GLUT1 deficiency syndrome exhibits abnormal sleep-wake patterns and alterations of glucose kinetics in the brain. Dis. Model. Mech. 12, dmm038828. doi:10.1242/dmm.038828
    OpenUrlAbstract/FREE Full Text
View Abstract
Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

RSSRSS

 Download PDF

Email

Thank you for your interest in spreading the word on Disease Models & Mechanisms.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First person – Tamio Furuse and Hiroshi Mizuma
(Your Name) has sent you a message from Disease Models & Mechanisms
(Your Name) thought you would like to see the Disease Models & Mechanisms web site.
Share
FIRST PERSON
First person – Tamio Furuse and Hiroshi Mizuma
Disease Models & Mechanisms 2019 12: dmm042127 doi: 10.1242/dmm.042127 Published 12 September 2019
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
FIRST PERSON
First person – Tamio Furuse and Hiroshi Mizuma
Disease Models & Mechanisms 2019 12: dmm042127 doi: 10.1242/dmm.042127 Published 12 September 2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • ABSTRACT
    • Footnotes
    • Reference
  • Figures & tables
  • Info & metrics
  • PDF

Related articles

Cited by...

More in this TOC section

  • First person – Celia Cordero-Sanchez
  • First person – Andrew Scott Emmert and Eri Iwasawa
  • First person – Claudia Figueroa-Romero and Benjamin Murdock
Show more FIRST PERSON

Similar articles

Other journals from The Company of Biologists

Development

Journal of Cell Science

Journal of Experimental Biology

Biology Open

Advertisement

Editor’s choice – Perturbed development of cranial neural crest cells in association with reduced sonic hedgehog signaling underlies the pathogenesis of retinoic-acid-induced cleft palate

Schematic showing that excessive RA signaling reduces Shh signaling, which results in elevated cell death of CNCCs and cleft palate.

Takashi Yamashiro and colleagues identify the critical role of the retinoic acid-Sonic hedgehog signalling pathway in cranial neural crest and palate development.


Featured article – Deep learning enables automated volumetric assessments of cardiac function in zebrafish

A graphical 3D reconstruction of ventricular EDV and ESV as measured by CFIN.

A new Resource article by Nguyen et al. describes CFIN, a novel deep learning image analysis platform to assess cardiac function in embryonic zebrafish. 


Review – CRISPR/Cas9-mediated genome editing in nonhuman primates

Two pictures of non-human primates commonly used in genome editing research.

Yuyu Niu and colleagues summarise the history of genome editing in non-human primates and discusses the challenges and prospects of the technology.


First person interviews

Pictures of Alexander and Jocelyn.

Have you seen our interviews with the early-career first authors of our papers? Recently, we caught up with Alexander Akerberg and Jocelyn Wessels. 


Travelling Fellowship – New imaging approach unveils a bigger picture

Highlights from Travelling Fellowships trips.

Find out how Pamela Imperadore’s Travelling Fellowship grant from The Company of Biologists took her to Germany, where she used new imaging techniques to investigate the cellular machinery underlying octopus arm regeneration. Don’t miss the next application deadline for 2020 travel, coming up on 29 November. Where will you go?


preLights – HSP110 dependent HSP70 disaggregation machinery mediates prion-like propagation of amyloidogenic proteins in metazoa

preLights logo

Highlighted by Tessa Sinnige, a recent preprint from Carmen Nussbaum-Krammer and co-workers shows that Hsp110 activity protects against amorphous protein aggregation but promotes amyloid aggregation and toxicity in C. elegans models.

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Subject collections
  • Interviews
  • Sign up for alerts

About us

  • About DMM
  • Editors and Board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • Biology Open transfer

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contact

  • Contact DMM
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2019   The Company of Biologists Ltd   Registered Charity 277992